Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Garrison Fathman

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Current Biology : CB|August 1, 1993
Stimulating the lymphocytesC Garrison Fathman
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2003
Costimulatory signals controlling regulatory T cellsJoerg Ermann, C Garrison Fathman
Immunologic Research|April 1, 2014
Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesisLinda Yip, C Garrison Fathman
Nature Immunology|March 22, 2006
CYLD: deubiquitination-induced TCR signalingNeil Lineberry, C Garrison Fathman
Immunity|May 23, 2006
T cell anergy: where it's LATNeil Lineberry, C Garrison Fathman
Annual Review of Medicine|January 18, 2006
Cd4+Cd25+ regulatory T cells and their therapeutic potentialDavid A Randolph, C Garrison Fathman
Nature Clinical Practice. Rheumatology|September 5, 2006
Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease?Ingo H Tarner, C Garrison Fathman
Nature Reviews. Immunology|July 7, 2007
Molecular mechanisms of CD4+ T-cell anergyC Garrison Fathman, Neil B Lineberry
The Journal of Clinical Investigation|October 7, 2004
Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunityRémi J Creusot, C Garrison Fathman
Clinical Immunology (Orlando, Fla.)|September 10, 2002
The potential for gene therapy in the treatment of autoimmune diseaseIngo H Tarner, C Garrison Fathman
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Current Biology : CB|August 1, 1993
Stimulating the lymphocytesC Garrison Fathman
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2003
Costimulatory signals controlling regulatory T cellsJoerg Ermann, C Garrison Fathman
Immunologic Research|April 1, 2014
Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesisLinda Yip, C Garrison Fathman
Nature Immunology|March 22, 2006
CYLD: deubiquitination-induced TCR signalingNeil Lineberry, C Garrison Fathman
Immunity|May 23, 2006
T cell anergy: where it's LATNeil Lineberry, C Garrison Fathman
Annual Review of Medicine|January 18, 2006
Cd4+Cd25+ regulatory T cells and their therapeutic potentialDavid A Randolph, C Garrison Fathman
Nature Clinical Practice. Rheumatology|September 5, 2006
Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease?Ingo H Tarner, C Garrison Fathman
Nature Reviews. Immunology|July 7, 2007
Molecular mechanisms of CD4+ T-cell anergyC Garrison Fathman, Neil B Lineberry
The Journal of Clinical Investigation|October 7, 2004
Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunityRémi J Creusot, C Garrison Fathman
Clinical Immunology (Orlando, Fla.)|September 10, 2002
The potential for gene therapy in the treatment of autoimmune diseaseIngo H Tarner, C Garrison Fathman
Pageof 8